Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 23/12/19971 min de lecture
Plascon, Inc., dba Anderson Plasma Center; Denial of Request for a Hearing and Revocation of U.S. License No. 572-003
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is denying the request for a hearing and revokes the establishment license (U.S. license number 572-003) and product license issued to Plascon, Inc., doing business as Anderson Plasma Center, for the manufacture of Source Plasma. The agency finds that there is no genuine and substantial issue of fact justifying a hearing on the revocation of Plascon's licenses. The licenses are revoked due to the firm's failure to comply with the applicable biologics regulations and license standards designed to ensure the safety, purity, and potency of the manufactured products.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →